Valuation: Compugen Ltd.

Market Cap 22Cr 19Cr 17Cr 16Cr 31Cr 2.05TCr 31Cr 208.34Cr 81Cr 1.01TCr 81Cr 79Cr 3.47TCr P/E 2026 *
-7.86x
P/E 2027 * -7.97x
Enterprise Value 22Cr 19Cr 17Cr 16Cr 31Cr 2.05TCr 31Cr 208.34Cr 81Cr 1.01TCr 81Cr 79Cr 3.47TCr EV / Sales 2026 *
22.9x
EV / Sales 2027 * 13.4x
Free-Float
97.92%
Yield 2026 *
-
Yield 2027 * -

Last Transcript: Compugen Ltd.

1 day+7.04%
1 week+12.87%
Current month+6.54%
1 month+0.88%
3 months+0.88%
6 months+47.10%
Current year+49.02%
1 week 2.09
Extreme 2.09
2.3
1 month 1.95
Extreme 1.95
2.3
Current year 1.51
Extreme 1.51
3.24
1 year 1.3
Extreme 1.295
3.24
3 years 0.53
Extreme 0.53
3.24
5 years 0.51
Extreme 0.51
8.17
10 years 0.51
Extreme 0.51
19.9
Manager TitleAgeSince
Chief Executive Officer - 23/09/2025
Director of Finance/CFO 42 15/08/2024
Chief Operating Officer 49 01/01/2024
Director TitleAgeSince
Director/Board Member 70 11/06/2018
Director/Board Member 59 11/06/2018
Director/Board Member - 01/07/2019
Date Insider Type Main position Quantity % Market Cap.
24/04Fiscal year

Chief Executive Officer

15,000 0.0159%
24/04Fiscal year

Chief Technology Officer

6,000 0.0063%
14/04Fiscal year

Chief Technology Officer

6,000 0.0063%
Change 5-day change 1-year change 3-year change Capi.($)
+7.04%+12.87%+31.03%+100.00% 22Cr
+0.64%+6.10%+1.87%+7.14% 4.91TCr
+0.92%+6.21%+408.85%+607.44% 4.02TCr
+1.89%+11.06%+25.75%-7.89% 3.46TCr
+5.46%+8.10%+21.83%+66.94% 3.31TCr
+1.20%+2.02%+9.79%+32.43% 2.52TCr
+2.51%+4.94% - - 1.7TCr
+2.58%+7.24%+71.03%+132.17% 1.59TCr
+0.49%+0.70%+13.80%+19.23% 1.38TCr
-1.14%+7.52%+14.75%-30.83% 1.33TCr
Average +1.85%+6.38%+66.52%+102.96% 2.42TCr
Weighted average by Cap. +1.33%+6.73%+88.37%+131.00%

Financials

2026 *2027 *
Net sales 94.14L 82.26L 75.54L 70.45L 1.34Cr 90Cr 1.36Cr 9.1Cr 3.52Cr 44Cr 3.53Cr 3.46Cr 151.47Cr 1.6Cr 1.4Cr 1.29Cr 1.2Cr 2.28Cr 152.78Cr 2.31Cr 16Cr 6.01Cr 75Cr 6.03Cr 5.89Cr 258.21Cr
Net income -2.76Cr -2.41Cr -2.21Cr -2.06Cr -3.91Cr -262.71Cr -3.98Cr -27Cr -10Cr -128.86Cr -10Cr -10Cr -444.01Cr -2.8Cr -2.45Cr -2.25Cr -2.1Cr -3.97Cr -266.67Cr -4.04Cr -27Cr -10Cr -130.8Cr -11Cr -10Cr -450.7Cr
Net Debt - -
Logo Compugen Ltd.
Compugen Ltd. is a therapeutic discovery company. The Company focuses on infrastructure to discover drug targets and develop therapeutics. The Company is engaged in the research, development and commercialization of therapeutic and product candidates. The Company's pipeline primarily consists of early and preclinical stage immuno-oncology programs based on drug targets discovered by the Company, primarily immune checkpoint and myeloid protein target candidates. These programs are focused on the development of cancer immunotherapy drugs with potential to harness the immune system to provide treatment solutions in areas of unmet medical needs in various cancer types and patient populations, both as monotherapy and in combination with other drugs. Its pipeline also includes a preclinical stage fusion protein autoimmune product candidate. Its fields of focus are oncology and immunology, with emphasis on its discovery capabilities on immuno-oncology.
Employees
75
Date Price Change Volume
02/26/02 $2.280 +7.04% 4,95,002
01/26/01 $2.130 -0.47% 1,73,439
30/26/30 $2.140 -0.93% 2,86,230
29/26/29 $2.160 +3.35% 2,57,138
26/26/26 $2.090 +3.47% 2,93,512
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
2.280USD
Average target price
4.600USD
Spread / Average Target
+101.75%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CGEN Stock